Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes

作者: John D. Baxter , Paul Webb

DOI: 10.1038/NRD2830

关键词: ThyroidHeart rateType 2 diabetesHormoneBlood lipidsInternal medicineBody weightWeight lossEndocrinologyBiologyObesity

摘要: Thyroid hormone excess has potentially useful effects, including lowering of serum cholesterol and reduction body fat. However, the therapeutic application this so far been hampered by deleterious effects on heart, muscle bone. This article reviews recent progress in development selective thyroid mimetics that seem to lack adverse actions associated with itself, making them a promising new strategy for treatment atherosclerosis, obesity type 2 diabetes. hormones influence heart rate, lipids, metabolic weight multiple aspects lipid, carbohydrate, protein mineral metabolism. Although increased levels can improve lipid profiles reduce fat, these positive are counterbalanced harmful Thus, attempts use cholesterol-lowering loss purposes have limited. over past decade, analogues capable uncoupling beneficial from developed. Such drugs could serve as powerful tools address two largest medical problems developed countries — atherosclerosis obesity.

参考文章(92)
Allison A. Ellington, Iftikhar J. Kullo, Chapter 8 Atherogenic Lipoprotein Subprofiling Advances in Clinical Chemistry. ,vol. 46, pp. 295- 317 ,(2008) , 10.1016/S0065-2423(08)00408-3
Luis A Videla, Virginia Fernández, Gladys Tapia, Patricia Varela, Thyroid hormone calorigenesis and mitochondrial redox signaling: upregulation of gene expression Frontiers in Bioscience. ,vol. 12, pp. 1220- 1228 ,(2007) , 10.2741/2140
Todd J Friends, Yolanda V Caringal, Pratik Devasthale, Arthur M P Doweyko, Dennis E Ryono, Minsheng Zhang, Tamara Dejneka, Jon J Hangeland, Johan Malm, Andrei Sanin, Thyroid receptor ligands ,(2004)
GM Hargrove, A Junco, NC Wong, Hormonal regulation of apolipoprotein AI. Journal of Molecular Endocrinology. ,vol. 22, pp. 103- 111 ,(1999) , 10.1677/JME.0.0220103
John D Baxter, Wolfgang H Dillmann, Brian L West, Russ Huber, J.David Furlow, Robert J Fletterick, Paul Webb, James W Apriletti, Thomas S Scanlan, Selective modulation of thyroid hormone receptor action. The Journal of Steroid Biochemistry and Molecular Biology. ,vol. 76, pp. 31- 42 ,(2001) , 10.1016/S0960-0760(01)00052-8
John D. Baxter, Paul Webb, Gary Grover, Tom S. Scanlan, Selective activation of thyroid hormone signaling pathways by GC-1: A new approach to controlling cholesterol and body weight Trends in Endocrinology and Metabolism. ,vol. 15, pp. 154- 157 ,(2004) , 10.1016/J.TEM.2004.03.008
Allison A Hedley, Cynthia L Ogden, Clifford L Johnson, Margaret D Carroll, Lester R Curtin, Katherine M Flegal, Prevalence of Overweight and Obesity Among US Children, Adolescents, and Adults, 1999-2002 JAMA. ,vol. 291, pp. 2847- 2850 ,(2004) , 10.1001/JAMA.291.23.2847
M RICOTE, C GLASS, PPARs and molecular mechanisms of transrepression Biochimica et Biophysica Acta. ,vol. 1771, pp. 926- 935 ,(2007) , 10.1016/J.BBALIP.2007.02.013
Victor A. B. Drover, Luis B. Agellon, Regulation of the Human Cholesterol 7α-Hydroxylase Gene (CYP7A1) by Thyroid Hormone in Transgenic Mice Endocrinology. ,vol. 145, pp. 574- 581 ,(2004) , 10.1210/EN.2003-0993